Carbidopa is a decarboxylase inhibitor used in conjunction with levodopa in patients with Parkinson's disease. Carbidopa inhibits the peripheral metabolism of levodopa, which allows a greater proportion of the levodopa to cross the blood–brain barrier for central nervous system effects,